Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Bluestein Sanfurd
   2. Issuer Name and Ticker or Trading Symbol
LABARGE INC [LB] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
2150 N. OCEAN BLVD., APT 4N		 3. Date of Earliest Transaction (Month/Day/Year)
06/23/2008
(Street)

BOCA RATON, FL 33431		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $.01 par value per share 06/23/2008   S   10,000 D $ 12.75 169,500 I See Note (1) (2)
Common Stock, par value $.01 par value per share               733,000 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Bluestein Sanfurd
2150 N. OCEAN BLVD., APT 4N
BOCA RATON, FL 33431		     X    

Signatures

 /s/ Sanfurd Bluestein   06/24/2008
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Dr. Bluestein indirectly owns these shares of common stock of the Issuer (the "Shares"), which are directly owned by the Bluestein Family Foundation, Inc. (the "Foundation"), a private foundation of which Dr. Bluestein is the Manager, and over which Dr. Bluestein shares voting and investment control pursuant to third party trading authorizations. Dr. Bluestein has elected to report the entire amount of the Foundation's interest in the securities of the issuer, pursuant to Instruction 4(b)(iv) of this Form. Dr. Bluestein directly beneficially owns 733,000 Shares. Additionally, Dr. Bluestein indirectly owns 137,000 Shares, which are directly owned by Oppenheimer & Co. Inc., custodian for Sanfurd G. Bluestein IRA, over which Dr. Bluestein has sole voting and investment control;
(2) (continued from Footnote 1) 175,000 Shares, which are directly owned by Bluestein Family Partnership, LP, a private foundation of which Dr. Bluestein is the Manager; 175,000 Shares, which are directly owned by Joel Bluestein, Dr. Bluestein's son; 10,800 Shares, which are directly owned by Doris Hasnas, Dr. Bluestein's sister; 55,000 Shares, which are directly owned by Jessica Ann Bishop Trust #2, for the benefit of Dr. Bluestein's granddaughter; and 60,000 Shares, which are directly owned by JR Trusts, LLC, which is wholly owned by Jessica Reisman Trust #1 and Jessica Reisman Trust #2, over which Dr. Bluestein has sole voting and investment control.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.